Study | Subjects | Diagnostic measures | Associations |
---|---|---|---|
Schönknecht et al., 2003 [57] | 88 AD, 17 CN |  | In AD, CSF tau was not correlated to MRI. |
Wahlund and Blennow, 2003 [48] | 23 MCI, 24 AD |  | At baseline, CSF Aβ1-42 was correlated with MRI. During the follow-up period, increases in tau and p-tau correlated with ventricular increase. |
de Leon et al., 2004 [46] | 32 stable CN, 13 CN progressed to MCI | Accuracy for prediction of CN progression to MCI: Baseline: MRI: 78%; CSF: 78% to 89%. | Hippocampal volume decrease correlates with P-tau231 increase and Aβ1-42 decrease. |
Hampel et al., 2005 [73] | 22 AD | Â | CSF p-tau231 correlated with baseline hippocampus and rates of hippocampal atrophy. |
Schoonenboom et al., 2005 [74] | 39 MCI |  | CSF Aβ1-42 was correlated with MRI and not tau. |
de Leon et al., 2006 [42] | 9 CN, 7 MCI | Accuracy for separation of CN and MCI: Baseline: MRI: 94%, CSF: 63% to 88%; MRI + CSF: 94% Longitudinal: MRI: 88%; CSF: 73% to 88%; MRI + CSF: 94% | In MCI, longitudinal hippocampal volume decrease correlated with P-tau231 increase and Aβ1-42 decrease. |
Herukka et al., 2008 [51] | 21 MCI, of whom 8 progressed to AD | Â | In all MCI, increases in tau and p-tau correlated with a decrease in hippocampal volumes. |
Schoonenboom et al., 2008 [56] | 32 CN, 61 AD | Odds ratio between AD and CN: MRI: 28; CSF: 57 | There were no correlations between visual assessment of MRI and CSF biomarkers within CN and AD. |
Sluimer et al., 2008 [52] | 23 CN, 9 MCI, 47 AD | Â | In AD, CSF p-tau181 had mild association with whole-brain atrophy rate. Only MRI was associated with change in cognitive measures. |
Brys et al., 2009 [45] | 21 CN, 16 stable MCI, 8 MCI progressed to AD | Accuracy for prediction of MCI progression to AD: MRI: 74%; CSF: 70%; MRI + CSF: 84% | There were no longitudinal correlations between MRI and CSF. |
Chou et al., 2009 [53] | 80 CN, 80 MCI, 80 AD (ADNI) |  | CSF Aβ1-42 was correlated with ventricular expansion. |
Fagan et al., 2009 [54] | 69 CN, 29 mild AD |  | In CN, decrease in CSF Aβ1-42 correlated with brain atrophy. In mild AD, increases in CSF t-tau and p-tau181 correlated with brain atrophy. |
Henneman et al., 2009 [49] | 19 CN, 25 MCI, 31 AD | Â | Baseline CSF p-tau181 was independently associated with subsequent disease progression, measured by hippocampal atrophy rate. |
Leow et al., 2009 [75] | 40 CN, 40 MCI, 20 AD (ADNI) | Â | Baseline CSF correlated with temporal atrophy rates over the course of 12 months. |
Schuff et al., 2009 [76] | 112 CN, 226 MCI, 96 AD (ADNI) |  | In MCI, an increase in rates of hippocampal atrophy correlated with lower CSF Aβ1-42. |
Thomann et al., 2009 [50] | 15 CN, 23 MCI (AACD), 16 AD | Â | Increases in CSF t-tau and p-tau181 correlated with cortical atrophy in temporal, parietal, and frontal regions. |
Vemuri et al., 2009 [43] | 109 CN, 192 aMCI, 98 AD (ADNI) | AUROC separating CN, aMCI, and AD: MRI: 0.77; CSF: 0.68 to 0.73; MRI + CSF: 0.81 | Within each clinical group, only MRI correlated with cognition in aMCI and AD groups. |
Vemuri et al., 2009 [47] | 109 CN, 192 aMCI, 98 AD (ADNI) | Proportional hazards for predicting time to conversion from aMCI to AD: MRI: 2.6; CSF: 1.7 to 2.0 | Baseline MRI was a better predictor of subsequent cognitive and functional decline than baseline CSF was. |
Vemuri et al., 2010 [34] | 92 CN, 149 MCI, 71 AD (ADNI) | Sample size required to detect treatment effects in AD: MRI: 100; CSF >105. | Longitudinal annual changes were observed only in MRI and not in CSF. Change in MRI was associated with change in cognitive measures. |
Walhovd et al., 2010 [44] | 42 CN, 73 MCI, 38 AD (ADNI) | Accuracy for baseline separation of CN and AD: MRI: 85%; CSF: 81.2%; CSF + MRI: 88.8% | In MCIs, only baseline MRI and FDG were correlated to (or predictive of) future clinical decline during 2 years. |
Fjell et al., 2010 [77] | 71 CN |  | Below a certain threshold, baseline CSF Aβ1-42 correlated with ventricular increase and volumetric brain decrease over the course of 1 year. |
Fjell et al., 2010 [55] | Baseline: 105 CN, 175 MCI, 90 AD (ADNI) | Â | In MCI and AD, baseline CSF measures were not related to baseline MRI but were related to longitudinal atrophy. Baseline MRI predicted change in cognition better than CSF did. |